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Introduction  
Intracranial Atherosclerosis 
Atherosclerosis is a systemic disease of the vessel wall. The atherosclerotic plaque 
develops due to the accumulation of lipids, inflammatory cells, smooth muscle cells, 
and extracellular matrix in the subendothelial space over time.1 Atherosclerotic 
plaques are mainly found at arterial bifurcations, branch points and vessel curvatures, 
whereas straight unbranching arterial segments are generally spared.2 Cerebral, 
cardiac, and peripheral atherosclerosis are leading causes of morbidity and mortality 
in the Western world.3-6 Although the higher risk of ICAS in patients of Asian, 
African, and Hispanic ethnicity compared to Caucasians was described already in 
1986,7 ICAS has long been a rather neglected research field in Europe and North 
America. In Chinese patients ICAS accounts for about 33–50% of ischemic strokes 
and >50% of TIA.8-10 As the majority of the world’s population is represented by 
Asians, ICAS is the most common vascular lesion in stroke patients worldwide.11 In 
Caucasians, ICAS accounts for ~1-12.4% of all ischemic stroke patients.12-15
Research on ICAS has exponentially increased over the last two decades.16 However, 
several aspects still remain to be investigated, such as the prevalence of ICAS in 
Northern Europe; the responsible factors for the development of atherosclerosis in 
different locations among ethnicities; the pathophysiological differences between 
extracranial atherosclerosis (ECAS) and ICAS; the optimal diagnostic screening and 
evaluation of ICAS lesions; the best medical treatment for patients with ICAS; the 
optimal candidates for revascularization therapy; and the ultimate clinical outcome in 
patients with ICAS. 
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Epidemiology 
The studies reporting the prevalence of ICAS include population-based, hospital-
admission-based, and autopsy studies.  
Autopsy studies have the major advantage to identify minor intracranial plaques and 
to investigate the histopathologic features of the intracranial plaque, but are affected 
by selection bias. In vivo studies are characterized by the limitations of the diagnostic 
imaging methods, which may be unable 1) to detect initial stages of ICAS; 2) to 
differentiate ICAS from stenoses of other etiology; and 3) to provide histopathologic 
composition and activity of the intracranial atherosclerotic plaque.16 One of the most 
striking and unresolved issue about ICAS is the large difference in prevalence among 
ethnicities.11 Literature regarding ICAS epidemiology will therefore be reviewed on a 
geographic basis.  
Asia 
In the early 1980s, a Japanese autopsy study showed that ICAS was more severe in 
ischemic stroke patients than in patients without stroke or cerebral hemorrhage.17
Another Chinese autopsy study showed a significantly higher prevalence of ICAS 
compared to ECAS, and a strong correlation between age and ICAS, with at least one 
50% stenosis in more than 50% of the patients reaching 90 years of age.18  
Population-based studies have been made possible by the high availability and low-
cost of transcranial Doppler (TCD). Two large Chinese TCD studies have shown 
ICAS to be present in ~6-7% of stroke free, asymptomatic subjects.19, 20 The 
prevalence of asymptomatic ICAS in the Chinese population therefore appears similar 
to the prevalence of asymptomatic ECAS in Caucasians, i.e. 2-8%.21
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In Chinese patients with at least one vascular risk factor (hyperlipidemia, 
hypertension, diabetes mellitus) middle cerebral artery (MCA) stenosis was found in 
12.6% of the subjects and the prevalence of MCA stenosis increased quadratically 
with increasing number of risk factors: from ~7% for one risk factor to ~30% for four 
risk factors.22 In Japanese patients undergoing coronary artery bypass graft, 50% 
ECAS was found in ~17% of the patients, and 50% ICAS in ~21%.23
In studies reporting the prevalence of symptomatic ICAS in stroke patients, digital 
subtraction angiography (DSA) has long been considered the gold standard, but non-
invasive methods have gained importance during the last years.24 One magnetic 
resonance angiography (MRA) study has shown that ICAS was present in ~35% of 
Indian ischemic stroke patients versus ECAS ~7%.25 In South Asians ischemic stroke 
patients, ICAS was found by MRA or TCD in 54% of the cases.26 Other 
ultrasonographical studies from China have confirmed the high prevalence of ICAS in 
Chinese stroke patients, which appears to vary between 30 and 54%.8, 26 The 
prevalence of ICAS in TIA patients is most likely as high as in ischemic stroke 
patients, although based on limited data from one ultrasonographical study reporting 
ICAS in 51% of Chinese TIA patients.9    
North America and Europe 
The interest towards ICAS in the Western world began to rise in the late 1950s when 
one of the first autopsy studies described the presence of atherosclerosis in the 
intracranial arteries.27 Already in the late 1960s, several studies had shown that ICAS 
occurred more frequently among black people compared to white.28-31 More recently, 
data from the Northern Manhattan Stroke Study have shown ICAS to be the cause of 
ischemic stroke in 1% of Caucasians, 6% of African Americans, and 11% of 
Hispanics.12 In Europeans, ICAS appears to be the cause of ischemic stroke in ~2-7% 
of the cases in Germany,13, 14 ~10% in Greece and ~12% in Spain.15, 32
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There are limited data on the prevalence of ICAS in the general population. In 
asymptomatic patients referred for carotid Doppler ultrasound, ICAS was identified in 
~13% of the patients by TCD.33 In Spain, ICAS appears to affect ~9% of stroke-free 
Caucasians with moderate-high vascular risk.34  
Risk factors 
Ethnicity is undoubtedly the major risk for ICAS. However, it remains unclear if 
ethnicity is an independent risk factor for ICAS or if the heterogeneity of risk factors 
presented in different ethnic groups represents a confounder. Most of the 
conventional cardio- and cerebrovascular risk factors have been associated also with 
ICAS. Advanced age is a strong risk factor for ICAS, and it has been suggested that 
ICAS develops one decade later in life compared with ECAS.35 Evidences about 
association between ICAS and gender are controversial, but some evidences suggest a 
male predominance in ICAS.7, 20, 36 Gender appears also to influence the progression 
of the ICAS. ICAS is found earlier in men but may progress faster in women, possibly 
due to menopausal hormonal changes.37 Both autopsy35 and clinical studies19, 22, 38-43
have found a strong association between hypertension and ICAS. Diabetes mellitus 
(DM) appears also to be a strong risk factor for ICAS, both in asymptomatic43 and 
symptomatic ICAS,15, 44, 45 possibly even stronger than hypertension. DM is closely 
associated also to both ICAS and ECAS.46, 47 Although hyperlipidemia is a well-
known risk factor for ECAS, its association to ICAS remains unclear and only few 
studies have found a strong association between hyperlipidemia and ICAS.22, 38
Metabolic syndrome is another composite risk factor which has recently been found to 
be more strongly associated to ICAS than ECAS.48-50
Studies which have compared the role of risk factors in ICAS and ECAS patients 
have shown discordant results. Several studies have suggested that hypertension is 
more closely associated with ICAS than hyperlipidemia, whereas hyperlipidemia may 
play a greater role than hypertension in patients with ECAS.7, 30, 40, 51 However, other 
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studies have failed to find difference in risk factors between these two groups of 
patients, and have suggested ethnicity as the only independent factor.36, 52, 53  
Stroke mechanisms 
The pathophysiology of the intracranial plaque does not substantially differ from 
atherosclerosis in other vessels such as coronary or carotid arteries. In situ thrombotic 
occlusion, artery-to-artery embolism, branch occlusive disease of the orifice of 
perforating arteries, hypoperfusion or the combination of these mechanisms lead to 
cerebral ischemia in patients with ICAS.54, 55 Advances in neurovascular imaging 
have improved our insight into stroke mechanisms in ICAS patients.  
In situ thrombotic occlusion 
Acute thrombosis superimposed on the intracranial atherosclerotic plaque is caused by 
the rupture of the plaque fibrous cap leading to release of tissue factors from the 
damaged endothelial surface.56 Secondary artery-to-artery embolism may coexist.57, 58
Among the stroke mechanisms in ICAS patients, in situ thrombotic occlusion usually 
leads to the largest infarcts. However, the gradual progression of atherosclerosis may 
allow the establishment of intracranial collaterals which may prevent a complete 
territorial infarction. The infarction area is therefore often limited to the 
striatocapsular area, borderzone area or both, and the final infarction size depends on 
the development of the collateral circulation. 
Branch occlusive disease 
Occlusive disease of deep central perforating arteries occurs when an intracranial 
atherosclerotic plaque protrudes and occludes the orifice of perforating arteries, 
leading to a subcortical lacunar-like infarct. Atheromatous branch occlusive disease 
must be differentiated from lipohyalinosis, which is characterized by segmental wall 
16
disorganization along the course of perforating arteries and usually related to 
hypertension. Lipohyalinosis is considered the common underlying cause of lacunar 
infarcts.  
Intracranial atheromatous branch disease has long been a “neglected, understudied, 
and underused concept”.59 Although branch occlusion is accurately detected only by 
anatomopathological studies, vascular imaging and DWI may provide some 
pathognomonic signs, such as coexistence of small subcortical infarct and ipsilateral 
intracranial stenosis. Asian studies have shown that many lacunar infarcts are caused 
by ICAS rather than lipohyalinosis.60-63 Clinical course and infarction size may help 
distinguish between these two diseases. Infarcts caused by branch occlusive disease 
may be characterized by symptoms fluctuation and are usually larger than lacunes 
caused by lipohyalinosis.60, 61 Occlusion of the perforating arteries may be caused by 
minor atherosclerotic plaques64 which are often overlooked by the routine intracranial 
vascular imaging. The actual prevalence of this mechanism therefore remains 
undefined and probably underestimated. 
Artery-to-artery embolism 
Distal artery-to-artery embolism from an intracranial stenosis to peripheral arterial 
segments often coexists with in situ thrombotic occlusion. Distal embolism of 
atherosclerotic debris may originate from plaque ulceration, and/or from disgregation 
of a thrombotic occlusion. Lesions causing artery-to-artery embolism may have higher 
degree of stenosis than lesions causing branch occlusion.64 High-grade stenosis may 
be associated with perfusion deficits in the territory of the stenotic vessel, leading to 
more severe distal embolic infarction through impaired emboli clearance.65 Diffusion-
weighted MR imaging (DWI) and microembolic signal (MES) monitoring are useful 
diagnostic tools to define a possible artery-to-artery mechanism in patients with 
cerebral infarction and ICAS. Coexistence of multiple small cortical infarctions at 
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DWI and detection of MES with TCD are highly suggestive for an underlying artery-
to-artery stroke mechanism. 
Hypoperfusion  
The atherosclerotic plaque may progressively obliterate the arterial lumen and 
eventually lead to hypoperfusion, if collaterals are insufficient. In these patients, TIA 
and/or ischemic stroke typically occur in concomitance with conditions disturbing 
cerebral perfusion, e.g. high-grade ECAS and inadequate circle of Willis.  
Hypoperfusion may coexist with other mechanisms. High-grade ICAS causing 
hypoperfusion may be unstable and undergo cap fissuring because of elevated share 
stress and turbulent flow. In patients with high-grade ICAS and small, multiple 
infarctions in the borderzone areas, hypoperfusion may contribute to infarction in 
these areas by reducing the emboli clearance.66-68 High-grade ICAS may also 
theoretically lead to hypoperfusion in the territories supplied by perforating arteries. 
The smaller the arterial lumen, the higher the intrastenotic blood flow velocity.69
According to the Bernoulli’s and the continuity principle, an increase in flow velocity 
is associated with a decrease in pressure (Venturi effect) to satisfy the principle of 
conservation of mechanical energy. In case of a high-grade MCA stenosis the high 
intrastenotic velocity might cause low pressure and thereby hypoperfusion in 
perforating arteries.70
Diagnostic imaging 
Digital subtraction angiography (DSA), magnetic resonance angiography (MRA), 
computed tomographic angiography (CTA) and transcranial ultrasonography 
(TCD/TCCS) are the available modalities for evaluation of intracranial arteries.  
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Digital subtraction angiography 
DSA is the current gold standard for imaging of the intracranial arterial pathology, 
included intracranial atherosclerosis.24 The superiority of DSA is due to high spatial 
and contrast resolution, which makes this modality the most accurate in the evaluation 
of the degree of intracranial stenosis. The standardized method used to measure the 
degree of stenosis with DSA defines the stenosis as percent stenosis based on 
prestenotic and intrastenotic diameters (Dp and Di), i.e. ΀ϭͲ;ŝͬƉͿ ǆ ϭϬϬ΁й͘71, 72
Despite the superior image quality, there are several drawbacks. DSA may incorrectly 
diagnose high-grade stenosis in case of slow blood flow. In such hemodynamic 
conditions, the contrast filling of the vessel distal to the stenosis is poor and may 
falsely suggest arterial occlusion.73 The bidimensional images provided by DSA may 
also overlook tortuosity and anatomical details which may be important in evaluation 
of patients addressed to stenting procedures. In TIA and ischemic stroke patients, 
DSA is associated with 3.0% risk of transient neurological deficit and 0.7% risk of 
permanent neurological deficit.74 DSA exposes also patients to ionizing radiation, 
peripheral vascular complications and possible allergic reactions to contrast agent. 
Continuous improvement of other non-invasive modalities is challenging the role of 
DSA as gold standard.  
Magnetic Resonance Angiography  
The use of MRA in ischemic stroke patients has increased exponentially in the last 
decade and several techniques are now available for detection of ICAS. The most 
common MRA technique is the 3D time-of-flight (TOF) sequence. TOF MRA 
appears to be reliable in excluding the presence of ICAS. Studies investigating the 
diagnostic performance of TOF MRA in detection of 50% intracranial stenosis with 
DSA as gold standard have shown that TOF MRA has high negative predictive value 
(91-98%) and high specificity (99%), whereas positive predictive value and 
sensitivity were lower (59-63 and 70% respectively).24, 73 However, TOF-MRA may 
overestimate the length and the degree of intracranial stenosis.75 This limitation may 
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be overcome by contrast-enhanced MRA (CE MRA), which adopts gadolinium as 
contrast agent.75 Even though CE MRA is promising, the necessity of contrast agents 
limits the routine use of CE MRA, and no study has compared the diagnostic 
performance of CE MRA with a gold standard.76    
Computed Tomographic Angiography  
Computed tomography (CT) utilizes X-rays to produce cross-sectional, bidimensional 
images. CT technology has improved since Godfrey Hounsfield in 1972 developed 
the first scanner, which required hours to acquire images slice by slice, and days for 
post-processing. Modern CT acquires multiple slices in one breath hold. CT 
angiography (CTA) is obtained by acquisition of images during the first pass of 
intravenous iodinated contrast agent. Although CTA is performed quickly, expensive 
workstations are required to post-process the enormous image datasets. There are 
mainly three post-processing techniques: 1) multiplanar reformation (MPR), which 
creates 2-D images in arbitrary planes; 2) maximum intensity projection (MIP), which 
shows both contrast filling and vessel calcification; and 3) volume rendering, which 
provides colour 3-D images.77 CTA has several advantages compared with MR and 
DSA. CTA is widely available and minimally invasive, quick to perform, less 
distorted from motion artifacts and less dependent from hemodynamic effects than 
MRA. With DSA as gold standard, CTA appears to have higher sensitivity (98% vs 
70%), and higher positive predictive value (93% vs 65%) than MRA in detection of 
intracranial stenosis.73 CTA may also be superior to DSA in detection of occlusion in 
the posterior circulation, especially in cases with slow flow.73 CTA may therefore be 
the modality of choice to diagnose patients with ICAS. Drawbacks of CTA are 
possible artifacts deriving from extensive vessel calcification, lower resolution than 
DSA, and the use of iodinated contrast agents.78 Another limitation of CTA is the lack 
of hemodynamic real-time assessment of the intracranial circulation. 
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Transcranial ultrasonography  
Basic principles 
The first ultrasound probe able to record blood flow velocity through the skull was 
introduced in 1982.79 This ultrasound probe was based on the Doppler effect, and 
therefore called transcranial Doppler (TCD). The TCD machines in use today do not 
considerably differ from the first prototype, and still exploits a 2 MHz probe which 
depicts moving blood and displays the Doppler spectrum on the screen (Figure 1). 
&ŝŐƵƌĞϭ͘dƌĂŶƐĐƌĂŶŝĂůŽƉƉůĞƌƐƉĞĐƚƌƵŵŽĨƚŚĞŵŝĚĚůĞĐĞƌĞďƌĂůĂƌƚĞƌǇ

In the late 1980s transcranial color-coded sonography (TCCS) was introduced. This 
ultrasound technique utilizes a phased array transducer which combines the brightness 
mode (B-Mode), producing grey scale bidimensional pictures of the brain, with the 
Doppler mode. In TCCS the recorded Doppler shift frequencies are also exploited to 
create a spatial colour map of blood velocity overlaid on the B-mode image, and has 
therefore been defined as color Doppler mode. Thus, TCCS provides the visualization 
of both brain anatomy and intracranial vessels, and may both simplify and improve 
the examination of cerebral hemodynamics.  
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Insonation of the intracranial vessels can be performed through several bone 
“windows”. The most commonly used windows are the transtemporal, the transnuchal 
(or transforaminal) and the orbital window. Examination techniques are similar in the 
two transcranial ultrasonographic technologies, but TCCS has the advantage of being 
guided by the color Doppler mode. Only TCCS examination technique will be 
presented here in detail. Transtemporal examination is performed by placing the 
transducer anterior to the upper insertion point of the auricle above the zygomatic 
arch. Insonation is performed using either axial or coronal plane. In the axial plane, 
several planes may be visualized tilting the transducer apically or caudally. It is 
recommended to start from the mesencephalic plane, which visualizes the midbrain as 
a hypoechogenic butterfly-like structure. In this plane, the whole circle of Willis 
(except the siphon) may be visualized with color Doppler (Figure 2). 
&ŝŐƵƌĞϮ͘ŽůŽƌͲĐŽĚĞĚŽǀĞƌǀŝĞǁŽĨƚŚĞŝƌĐůĞŽĨtŝůůŝƐǁŝƚŚd^
Dϭ͗ƐƉŚĞŶŽŝĚĂůƐĞŐŵĞŶƚŽĨƚŚĞŵŝĚĚůĞĐĞƌĞďƌĂůĂƌƚĞƌǇ;DͿ
DϮ͗ŝŶƐƵůĂƌƐĞŐŵĞŶƚŽĨƚŚĞD
͗ĂŶƚĞƌŝŽƌĐĞƌĞďƌĂůĂƌƚĞƌǇ
W͗ƉŽƐƚĞƌŝŽƌĐĞƌĞďƌĂůĂƌƚĞƌǇ
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The siphon may be visualized by tilting the transducer further caudally.  
The coronal plane is achieved by turning the transducer 90°. The anterior coronal 
plane is performed by tilting the transducer forwards. In this plane, the terminal 
siphon segment and its bifurcation into the middle and the anterior cerebral arteries 
may be visualized. By tilting the transducer backwards, the top of basilar and its 
bifurcation into the superior cerebellar arteries and the posterior cerebral arteries may 
be visualized. Other insonation approaches are the transorbital examination, 
performed by placing the transducer on the closed eyelid, and the transnuchal 
examination, performed by placing the transducer suboccipitally on the midline. 
Using the orbital ultrasound window the ophthalmic artery and the siphon may be 
visualized. Through the transnuchal bone window the distal segment of the 
intracranial vertebral artery and the proximal segment of the basilar artery may be 
depicted.        
Diagnostic criteria 
Detection of an intracranial stenosis with ultrasound is based on the principle that 
reduction in the vessel lumen leads to an increase of the blood flow velocity (BFV). If 
a focal velocity increase is found, the degree of stenosis is defined comparing the 
highest BFV measurement to BFV thresholds. To define the best BFV thresholds in 
detection of intracranial stenosis, ultrasonographic examinations of normal and 
stenotic arteries have been compared with a reference method, usually digital 
subtraction angiography. TCD diagnostic criteria are based on mean velocity (MV) 
threshold values while TCCS usually employs peak systolic velocity (PSV) 
measurements. Several threshold values have been tested against different gold 
standard modalities for detection of 50% stenosis. A summary of the diagnostic 
performance of threshold values in detection of MCA stenosis by both TCD and 
TCCS are shown in Table 1.  

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dĂďůĞϭ͘ŝĂŐŶŽƐƚŝĐƉĞƌĨŽƌŵĂŶĐĞŽĨƚŚƌĞƐŚŽůĚǀĂůƵĞƐŝŶĚĞƚĞĐƚŝŽŶŽĨшϱϬйDƐƚĞŶŽƐŝƐ
d  ^ĞŶƐŝƚŝǀŝƚǇ ^ƉĞĐŝĨŝĐŝƚǇ WWs EWs
  й й й й
Ds
шϴϬĐŵͬƐĂ ϵϮ ϵϮ ϴϵ ϵϴ
шϭϬϬĐŵͬƐĂ ϭϬϬ ϵϳ ϴϴ ϭϬϬ
шϭϬϬĐŵͬƐď ͲͲͲ ͲͲͲ ϱϱ ϴϯ
шϭϬϬĐŵͬƐĐ ϳϴ ϵϯ ϳϯ ϵϰ
d^ 
W^s шϮϮϬĐŵͬƐĚ ϭϬϬ ϭϬϬ ϭϬϬ ϭϬϬ
WWs͗ƉŽƐŝƚŝǀĞƉƌĞĚŝĐƚŝǀĞǀĂůƵĞƐ  EWs͗ŶĞŐĂƚŝǀĞƉƌĞĚŝĐƚŝǀĞǀĂůƵĞƐ
ĂͿEĂǀĂƌƌŽ:͕ĞƌĞďƌŽǀĂƐĐŝƐ͘ϮϬϬϳ͖Ϯϯ͗ϯϮϱͲϯϯϬϴϬ 
ďͿ&ĞůĚŵĂŶŶ͕EĞƵƌŽůŽŐǇ͘ϮϬϬϳ͖ϲϴ͗ϮϬϵϵͲϮϭϬϲϮϰ
ĐͿŚĂŽ>͕^ƚƌŽŬĞ͘ϮϬϭϭ͖ϰϮ͗ϯϰϮϵͲϯϰϯϰϴϭ
ĚͿĂƵŵŐĂƌƚŶĞƌZt͕^ƚƌŽŬĞ͘ϭϵϵϵ͖ϯϬ͗ϴϳͲϵϮϴϮ
Several velocity thresholds have been proposed and tested to diagnose stenosis in the 
other segments of the circle of Willis (Table 2). 
dĂďůĞ Ϯ͘ ŝĂŐŶŽƐƚŝĐ ƉĞƌĨŽƌŵĂŶĐĞ ŽĨ ƚŚƌĞƐŚŽůĚ ǀĂůƵĞƐ ŝŶ ĚĞƚĞĐƚŝŽŶ ŽĨ шϱϬй ƐƚĞŶŽƐŝƐ ŝŶ
ŽƚŚĞƌĐŝƌĐůĞŽĨtŝůůŝƐƐĞŐŵĞŶƚƐ
 d^Ă ^ĞŶƐŝƚŝǀŝƚǇ ^ƉĞĐŝĨŝƚǇ dď ^ĞŶƐŝƚŝǀŝƚǇ ^ƉĞĐŝĨŝƚǇ
 W^s;ĐŵͬƐͿ й й Ds;ĐŵͬƐͿ й й
 шϭϱϱ ϭϬϬ ϭϬϬ шϴϬ ͲͲͲ ͲͲͲ
/Đ шϭϮϬĐ ϴϳĐ ϴϯĐ шϴϬĐ ϵϯĐ ϳϲĐ
W шϭϰϱ ϭϬϬ ϵϭ шϱϬ ͲͲͲ ͲͲͲ
ĂƐŝůĂƌ шϭϰϬ ϭϬϬ ϭϬϬ шϴϬĚ ϲϵĚ ϲϵĚ
sĞƌƚĞďƌĂů шϭϮϬ ϭϬϬ ϭϬϬ шϴϬĚ ϲϵĚ ϲϵĚ
ĂͿĂƵŵŐĂƌƚŶĞƌZt͕^ƚƌŽŬĞ͘ϭϵϵϵ͖ϯϬ͗ϴϳͲϵϮϴϮ
ďͿůĞǆĂŶĚƌŽǀs͕ĞƌĞďƌŽǀĂƐĐƵůĂƌƵůƚƌĂƐŽƵŶĚŝŶƐƚƌŽŬĞƉƌĞǀĞŶƚŝŽŶĂŶĚƚƌĞĂƚŵĞŶƚ͘tŝůĞǇ͖ϮϬϭϭϴϯ
ĐͿzŽƵz͕:EĞƵƌŽŝŵĂŐŝŶŐ͘ϮϬϭϬ͖ϮϬ͗ϮϯϰͲϮϯϵϴϰ
ĚͿŚĂŽ>͕^ƚƌŽŬĞ͘ϮϬϭϭ͖ϰϮ͗ϯϰϮϵͲϯϰϯϰϴϭ
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The reliability of these diagnostic criteria will be discussed in the “Discussion” 
section.  
Ultrasound contrast agents  
Ultrasound contrast agents (UCA) are micron-sized bubbles containing low-soluble 
gas and surrounded by a thin outer layer or shell of phospholipids, sugars or polymer 
coating.85 Gas-filled microbubbles scatter ultrasound much more effectively than a 
liquid or solid-filled microbubble of comparable size, and hence increase the 
magnitude of the received echo. UCA are used in all imaging modalities to increase 
the sensitivity of the imaging technique by increasing the image contrast between 
different structures.  
UCA have been an active area of research since 1968, when opacification of the right 
cardiac ventricle was observed after injection of saline.86 During the last three 
decades there has been efforts to develop stabilized microbubbles capable of trans-
pulmonary passage for left side blood pool enhancement.87 Since the introduction of 
UCA in neurosonology in 1993,88 the application of UCA in this field has 
considerably increased. Common applications employing UCA include transcranial 
ultrasound studies in patients with severe hyperostosis of the skull, quantification of 
internal carotid stenosis in the presence of calcification, imaging of the carotid plaque 
angiogenesis89 and brain perfusion.90, 91
Fundamental properties of ultrasound contrast agents 
UCA used before commercial manufacture of UCA, i.e. agitated saline or dyes, 
tended to be large (>10 μm). Current UCA are comparable in size to red blood cells 
(2-6 μm), and are thereby able to pass through the lung capillary, arrive into the left 
ventricle, and be delivered to the intracranial vasculature. The behavior of UCA 
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within the ultrasound beam is complex and depends on several factors including shell 
composition, transmit frequency, and transmit power. The large difference between 
the acoustic impedance of plasma and the encapsulated gas generates much stronger 
echoes than those produced by RBC.92 Gaseous microbubbles insonated by the 
ultrasound beam are forced to oscillate – contracting during the positive part of the 
ultrasound wave cycle and expanding during the negative part of the cycle. The 
degree of scattering and oscillation is maximum if the ultrasonic wave is at the 
resonant frequency of the microbubbles.85 The microbubble resonance frequency 
depends on the size of microbubbles and lies within the clinical diagnostic frequency 
range of ultrasound. The reaction of microbubbles varies also according to the 
acoustic pressure (pr). At low acoustic pressure (pr<0.1 megaPascal [MPa]), the 
majority of microbubbles oscillates symmetrically in the ultrasound beam, contracting 
during the positive part of the cycle and expanding during the negative part of the 
cycle. The scattered ultrasound signal from the microbubble will therefore be the 
same as the ultrasound wave sent from the probe (incident wave). This is known as 
linear behavior. As the acoustic pressure increases (0.1<pr<1.4 MPa), the expansion 
of the bubble during the negative phase will be different from the compression in the 
positive phase. During the negative phase, the bubble’s radius can increase by as 
much as several hundred percent. During the positive phase, the gas inside the bubble 
rapidly stiffens as the molecules are forced closer together, and makes the bubble less 
compressible. This results in an asymmetric nonlinear bubble oscillation, which 
produces an echo with asymmetric top and bottom, instead of a sinusoidal echo. This 
asymmetry in the scattered ultrasound wave produces harmonics which can be 
exploited to differentiate the bubbles signals from the surrounding tissue. At even 
higher acoustic pressure (pr1.4 MPa), the shell of the microbubbles may rupture, and 
release the gas from microbubble. The resulting free gas bubbles will strongly scatter 
ultrasound. However, they will rapidly dissolve into the bloodstream and will 
therefore only be visualized in few ultrasound frames. This strong interaction between 
the microbubbles and the high pressure ultrasound pulse will result in a scattered 
wave with a wide range of frequency components. Acoustic pressure is therefore an 
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important parameter when performing contrast-enhanced ultrasound. This parameter 
is not displayed by ultrasound scanners. However, the mechanical index (MI) can be 
used as an indicator of the likelihood of bubble rupture because MI is proportional to 
the acoustic pressure: D/ сƉƌ ͬ яĨ, where Ɖƌ is the peak rarefaction pressure of the 
ultrasound wave in situ (peak negative pressure) and Ĩ is the ultrasound frequency.   
Contrast-enhanced transcranial ultrasound 
Excessive signal attenuation by the skull occurs in 5% to 25% of patients.93, 94 UCA 
overcome this limitation in almost all patients with poor transtemporal window.95 The 
introduction of UCA therefore rendered possible otherwise failed Doppler exams.96
UCA are administered intravenously either as bolus injection or as continuous 
infusion. UCA bolus injection results in a wash-in-wash-out enhancement curve 
characterized by a rapid increase and a short peak of strong enhancement, with 
subsequent decay over a few minutes. The duration of diagnostically useful 
enhancement is therefore relatively short (2-5 minutes), and blooming commonly 
occurs.97 Blooming is an undesired saturation artifact compromising image quality 
and hindering Doppler measurement. It occurs when the intensity of the backscattered 
signal is too high, and is characterized by a false colour Doppler signal which extends 
outside the actual width of the vessel and covers most part of the Doppler sector. 
Blooming occurs commonly during the peak of contrast-enhancement after UCA 
bolus injection or if the rate of UCA continuous infusion is too high. Proper UCA 
continuous infusion prolongs the enhancement duration, avoids saturation artifacts, 
and provide a constant plateau of enhancement throughout the duration of infusion. In 
patients with poor transtemporal bone window, a stable and diagnostically useful 
enhancement contrast enhancement is reached by 0.4-0.5 ml/minute infusion rate and 
kept for 10-12.5 minutes. UCA continuous infusion should therefore be considered 
the method of choice.  
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Another pitfall related to UCA is an artificial increase in measured blood flow 
velocity (BFV). This phenomenon has been observed in studies administering UCA in 
patients with optimal transtemporal bone window and comparing the BFV measured 
before and after bolus injection.98, 99 A 20–24 % increase in measured peak systolic 
velocity (PSV) after UCA bolus injection has been reported.98, 99 The reason for the 
UCA-related increase in measured BFV remains unclear and still debated. Possible 
explanations will be presented and discussed in the “Discussion” section. The 
artificial increase in measured BFV caused by UCA implies diagnostic and clinical 
consequences. Current neurosonographic diagnostic criteria for intracranial stenosis 
are based on threshold BFV.80, 82 A falsely elevated BFV will therefore lead to false 
positive cases or overestimation of the degree of the intracranial stenosis.  
Ultrasound measurement of the cerebral blood flow 
Transcranial ultrasound provides reliable measurements of blood flow velocity (BFV) 
which are accurate in detection of intracranial stenosis and occlusion.80, 82, 100 BFV 
may be used as a surrogate of cerebral blood flow volume. Relationship between BFV 
and cerebral blood flow volume is defined by the formula &сsΎ, where & is the 
cerebral blood flow volume, s is the BFV, and  is the area of the cerebral vessels. If 
the area is constant, flow volume and velocity change proportionally. However, 
cerebral arteries are extremely reactive and changes in the vascular bed make BFV no 
longer directly proportional to the cerebral blood flow volume. Thus, it is challenging 
to interpret changes in velocity without knowledge of the area of the vascular bed. 
TCCS provides anatomical visualization of the brain in the brightness-mode (B-
Mode). The resolution with this technology is, however, too poor to provide sufficient 
anatomical information of the intracranial vessels, and it is therefore not possible to 
measure the diameter of the intracranial vessels. However, it has long been known 
that blood flow volume can be estimated by analyzing the Doppler spectrum.101 Blood 
velocity measurements are based on the Doppler shift. The Doppler spectrum is the 
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result of many red blood cells (RBC) moving in the Doppler sample volume at 
different velocity. The received ultrasound signal therefore contains not just one 
frequency, but a spectrum of frequencies. Despite moving at different velocities, the 
received signal from each RBC has equal power. The power of the reflected Doppler 
signal is thus proportional to the number of RBC, and to the cross-sectional area of 
Doppler sample volume. Considering that 1) blood flow velocity may be expressed by 
Doppler shift frequency, 2) the power of the reflected Doppler signal is proportional 
to the cross-sectional area and 3) &сsΎ (see above), an estimation of the blood 
flow volume, expressed as a flow index, can be calculated from the weighted sum of 
each Doppler frequency (Ĩŝ), and the corresponding power signal (Wŝ), i.e. flow index 
(&/) с є Į Ύ Wŝ. The flow index does not provide an absolute value of the cerebral 
blood flow but a series of instantaneous estimations which may detect relative 
changes in flow volume. Once the flow index has been calculated, an estimation of 
the cross-sectional area (area index, /) may be derived by the formula: /с&/ͬs. 
However, several factors may distort the insonating ultrasound beam and the reflected 
Doppler signal, and hinder the correct calculation of the flow index. The major 
disturbing factor is represented by the heterogeneity of tissues lying between the 
transducer and the vessel, and most specifically the temporal bone, which causes 
attenuation and refraction of the ultrasound beam and non-uniform insonation of the 
vessel.102, 103  
The development of a feasible and reliable estimation of the blood flow volume may 
have important clinical applications and is therefore a focus for continuous research.  
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Aims of the thesis  
ϭ͘ dŽĂƐƐĞƐƐƚŚĞƉƌĞǀĂůĞŶĐĞŽĨƐǇŵƉƚŽŵĂƚŝĐĂŶĚĂƐǇŵƉƚŽŵĂƚŝĐŝŶƚƌĂĐƌĂŶŝĂůĂƚŚĞƌŽƐĐůĞƌŽƐŝƐ
ŝŶĂEŽƌǁĞŐŝĂŶ͕ĐŽŵŵƵŶŝƚǇͲďĂƐĞĚ͕ŝƐĐŚĞŵŝĐƐƚƌŽŬĞĂŶĚd/ƉŽƉƵůĂƚŝŽŶ͘
We hypothesized a relative low prevalence of intracranial atherosclerosis. This 
hypothesis is discusses in Paper I 
Ϯ͘ dŽ ĂƐƐĞƐƐ ƚŚĞ ĚŝĂŐŶŽƐƚŝĐ ƉĞƌĨŽƌŵĂŶĐĞ ŽĨ ĂŶ ƵůƚƌĂƐŽŶŽŐƌĂƉŚŝĐ ŵĞƚŚŽĚ ďĂƐĞĚ ŽŶ
ĐŽŶƚŝŶƵŝƚǇ ĞƋƵĂƚŝŽŶ ŝŶ ĚĞƚĞĐƚŝŽŶ ĂŶĚ ŐƌĂĚŝŶŐ ŽĨ ŝŶƚƌĂĐƌĂŶŝĂů ƐƚĞŶŽƐŝƐ͕ ǁŝƚŚ d ĂƐ
ƌĞĨĞƌĞŶĐĞŵĞƚŚŽĚ͘
We hypothesized the continuity equation method to be superior to the cut-off 
velocity method in detection of intracranial stenosis. This hypothesis is discussed 
in Paper II.  
ϯ͘ dŽĂƐƐĞƐƐƚŚĞĞĨĨĞĐƚŽĨďŽƚŚhĐŽŶƚŝŶƵŽƵƐŝŶĨƵƐŝŽŶĂŶĚŐĂŝŶƌĞĚƵĐƚŝŽŶŽŶƚƌĂŶƐĐƌĂŶŝĂů
ŽƉƉůĞƌŵĞĂƐƵƌĞŵĞŶƚƐŽĨďůŽŽĚĨůŽǁǀĞůŽĐŝƚǇ͘
We hypothesized that UCA continuous infusion leads to an increase in measured 
blood flow velocity and that optimal gain reduction is able to restore the blood 
flow velocity measured at baseline. This hypothesis is discussed in Paper III.   
ϰ͘ dŽĂƐƐĞƐƐǁŚĞƚŚĞƌĂŶĂůǇƐŝƐŽĨŽƉƉůĞƌƐƉĞĐƚƌƵŵƐŝŐŶĂůŵĂǇĚĞƚĞĐƚƌĞůĂƚŝǀĞĐŚĂŶŐĞƐŝŶ
ďůŽŽĚĨůŽǁǀŽůƵŵĞ͘
We hypothesized that a flow index calculated from the weighted sum of each 
Doppler frequency and the corresponding power signal detects relative changes in 
blood flow volume. This hypothesis is discussed in Paper IV 
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Material and Methods  
The data for papers I, II, III were obtained from a cohort of the Bergen NORSTROKE 
study. The study period was 18 months for paper I and 10 months for paper II. All 
patients with diagnosed ischemic stroke or TIA were included in Paper I. Patients 
with intracranial stenosis undergoing both CT-angiography (CTA) and transcranial 
color-coded sonography (TCCS) were included in paper II. Ten patients with TIA or 
minor stroke with normal CTA were included in paper III.  
The data for paper IV were obtained from in vitro experiments on a closed-loop 
phantom. In vitro experiments were carried out at the Department of Medical 
Engineering, Hochschule Ulm, University of Applied Sciences, Ulm, Germany.  
Bergen NORSTROKE study  
The Bergen NORSTROKE study is a prospective study which includes all ischemic 
stroke and TIA patients admitted to the Centre for Neurovascular Diseases, 
Department of Neurology, Haukeland University Hospital, Bergen, which serves a 
well-defined population of 244 170 inhabitants.104 After obtaining patient-signed 
informed consent, demographical and clinical data, laboratory and radiological 
findings and outcome were registered. The study was approved by the local ethics 
committee.  
Diagnostic work-up 
In paper I, II, and III, the patients diagnostic work-up included ECG, Holter 
monitoring, echocardiography, and extracranial Duplex ultrasonography. Intima-
media thickness was measured in the right distal carotid common artery. Extracranial 
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carotid artery stenosis was defined as <50% or 50% based on percentage of area 
reduction at ultrasonography. A multimodal, non-invasive approach including TCCS, 
CTA and MR-Angiography (MRA) was chosen to investigate the presence of ICAS.  
Transcranial color-coded sonography  
TCCS was performed in all patients on the day after admission (day 1). All TCCS 
examinations were performed by the Ph.D. candidate (N.L.) using a S5-1 probe 
(iU22, Phillips Medical Systems, Bothell, WA, USA). The intracranial internal 
carotid artery (ICA), the middle cerebral artery (M1 and M2 segments), the anterior 
cerebral artery (A1 and A2 segments) and the posterior cerebral artery (P1 and P2 
segments) were insonated by the transtemporal bone window bilaterally. Peak systolic 
velocity (PSV) was measured from the origin to the distal part of each segment with a 
2 mm sample volume, a stepwise depth decrement of 1 mm, and a stepwise optimal 
angle correction of Doppler sampling. The localization of the Doppler sample volume 
was confirmed by updating the color flow image at every step.  
Transcranial Doppler and contrast-enhanced transcranial Doppler  
With the patient in supine position, TCD examinations were performed using a 2 
MHz probe (Companion III Nicolet Vascular, Madison, WI, USA) secured to the 
patient’s head using a head band. The right MCA was insonated with a 15-mm sample 
volume centered at 52 mm insonation depth. SonoVue (Bracco, Italy), a microbubble 
contrast agent containing sulphur hexafluoride gas stabilized by phospholipids, was 
used as ultrasound contrast agent (UCA). UCA was administered via antecubital fossa 
venous access using an infusion pump (VueJect, Bracco, Italy).  
CT and CTA  
CT was performed in all patients on admission. If not contraindicated, CTA was 
performed on admission in patients admitted within 6 hours from stroke symptoms, 
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whereas in patients admitted after 6 hours from stroke symptoms CTA was performed 
if TCCS and/or MRA identified ICAS. The CT scanners used were GE Lightspeed 
Ultra or Toshiba Aquillion 64. Contrast injection rate was 5 ml/s iv with a total 
contrast volume of 80 ml for the GE Lightspeed ultra and 70 ml for the Toshiba 
Aquillion 64. Either Visipac 320 mg/ml or Iomeron 350 mg/ml was used in all cases. 
The same intracranial segments investigated with TCCS were evaluated with CTA for 
stenosis and occlusions. All measurements were done using AGFA IMPAX 4.5 
workstation for 3D reconstructions with volume rendering technique to aid in 
detection and characterization of stenosis.  
After identification of a candidate stenosis, reduction in luminal caliber was 
documented on the 2D grayscale MPR images. Prestenotic (Dp) and intrastenotic (Di) 
diameters were measured by an electronic ruler. Percent stenosis was calculated as: 
΀ϭͲ;ŝͬƉͿ ǆ ϭϬϬ΁й͘71 All image interpretation and measurements were made by a 
neuroradiologist (J.L.) who was aware of the presence of stenosis, but was blinded to 
site and degree of stenosis. CTA represented the reference method in Paper II.  
MRI and MRA 
Diffusion weighted MRI and time-of-flight MRA were performed as part of a routine 
MRI protocol for stroke patients on Siemens Magnetom 1.5 Tesla (Symphony) in all 
patients on day 1 if not contraindicated. The investigated arterial segments were the 
same as for TCCS and CTA. The degree of stenosis was defined following the 
WASID method72 and grouped into <50% and 50%. 
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Diagnostic criteria for intracranial stenosis and intracranial 
atherosclerosis 
CTA and MRA diagnostic criteria for intracranial stenosis (IS) used in paper I and II 
have been presented in the CT-CTA and MRI-MRA section.  
An IS was indicated by a focal increase in blood flow velocity (BFV). The focal 
increase in BFV was defined as ΀ϭʹ;W^sƉƌĞƐƚĞŶŽƚŝĐͬW^sŝŶƚƌĂƐƚĞŶŽƚŝĐͿǆϭϬϬ΁й͖105 PSV = peak 
systolic velocity. This formula has been derived from the continuity equation 
principle.69 The diagnostic threshold for IS was set at 26%. Each stenosis was 
therefore defined as percent area reduction between 26% and 99%. PSVintrastenotic was 
defined as the highest velocity measured in the area of focal velocity increase. 
PSVprestenotic was defined as the most distal velocity measurement before focal velocity 
increase. 
IS were also divided in < or 50% stenosis according to three different methods:       
a) continuity equation, i.e. ΀ϭʹ;W^sƉƌĞƐƚĞŶŽƚŝĐͬW^sŝŶƚƌĂƐƚĞŶŽƚŝĐͿǆϭϬϬ΁й; b) published and 
widely used82 velocity cut-off values which define stenosis as <50% if PSVintrastenotic
155 cm/s and <220 cm/s, or as 50% if  PSVintrastenotic 220 cm/s; c) cut-off velocity 
value which provided the highest sensitivity and specificity for MCA stenosis 50% 
in our study, i.e. 180 cm/s. IS was diagnosed if detected by either TCCS, CTA or 
MRA.  
IS was considered atherosclerotic (ICAS) if possible or probable cardioembolic 
causes or other defined causes (e.g. vasculitis, dissection) were ruled out by clinical 
and diagnostic work-up. ICAS was considered symptomatic if located in the arterial 
segment supplying the infarct area.  
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In vitro closed-loop phantom 
The in vitro experiments investigating the feasibility and reliability of a software 
designed to calculate a flow index from the sum of frequency-weighted calculations 
of the Doppler power (page 27-28) were performed using a closed-loop system of 
silicon tubes containing saline and human whole blood.  
Blood was obtained from the local transfusion bank, having exceeded its clinical 
usage date the previous day. Forward flow was generated using a digital roller pump, 
(Ismatec, MCP Process Pump, Glattburg, Switzerland). The blood was heparinized, 
kept in constant flow and continuously filtered using a micro-filter to prevent 
contamination by either gas bubbles or solid micro-particles.  A Windkessel function 
was built into the system. A constant temperature of 32°C was maintained within the 
closed-loop system by passing the tubes through a heated water bath and the 
temperature was monitored using a digital thermometer (BBC, Goerz metrawatt, 
M4051, Austria).  
Four different silicone tubes with inner diameters of 1.5, 2, 3 and 4 mm and a wall 
thickness of 0.5 mm were insonated with a 2 MHz TCD probe (DWL Compumedics, 
Singen, Germany). Each of the four tubes was insonated through a 5 mm thick 
Plexiglas and a water bath, and examined with constant power and gain settings. The 
probe was secured at a 45° angle of insonation with a specially designed Plexiglas 
holder. The sample volume length and the insonation depth were varied until the 
maximum Doppler power signal was obtained. By maximizing the received signal 
power, it can be assumed that the maximum beam intensity lies within the central 
region of the parabolic flow in the tube being insonated, i.e. the area of highest flow 
velocities. Maximizing the signal power is also necessary to ensure that the insonating 
beam intensity distribution is approximately equal for each tube studied. The high-
pass frequency filter was set to a standard setting of 100 Hz. Frequency-weighted first 
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moment calculations of the Doppler power were made using specifically designed 
software. The measurements were recorded and averaged over a ten second period. 
Calculated flow index and velocity values were then vertically shifted to pass through 
the zero intercept with a velocity value of zero corresponding to flow index value of 
zero (off-set corrected). To enable calculation of relative changes (percentage) in both 
flow and area indices the flow index value in the largest tube (4 mm diameter) was 
designated to be 100%. Flow index measurements were made at flow rates of 150, 
240 and 320 ml/min. 
Heparinized whole blood with an initial hematocrit (Hct) value of approximately 60% 
was used for all recordings. The closed-loop system was initially filled with 0.9% 
saline and all gas bubbles removed. Heparinized whole blood was added gradually to 
the system and the saline removed. Extreme care was taken not to introduce gas 
bubbles as blood was injected. Blood was allowed to flow through the system for at 
least 3 minutes before recordings. Increasing Hct values were measured directly using 
a centrifuge (Hemokrit 4, Lic Instruments, Stockholm, Sweden) and Hct graph 
(Heræus sepatech, Osterode/Harz, Germany). Doppler measurements were then 
carried out at the 3 different flow rates above and at Hct values of 10, 20, 29 and 
42%. The Hct value was controlled at the end of each set of recordings for each flow 
value, to ensure it had not fallen. 
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Results 
Prevalence of intracranial atherosclerosis (Paper I) 
The prevalence of intracranial atherosclerosis was calculated by screening 607 
consecutive ischemic stroke or TIA patients which were admitted to our 
Neurovascular Centre over an 18-month study period. MRA was performed in 533 
(87.8%) and CTA in 227 patients (37.4%). TCCS was performed in all patients and a 
fair/good transtemporal bone was found in 485 patients (79.9%). At least one vascular 
imaging method was available in 575 patients (94.7%). Out of the 607 patients 
admitted with an ischemic event, 562 had ischemic stroke and 45 TIA. Intracranial 
stenosis was found in 54 patients (8.9%; 95% CI: 6.6% - 11.1%). Seven patients 
presenting intracranial stenosis had a possible or probable cardioembolic cause, and 
intracranial atherosclerosis was therefore diagnosed in the remaining 47 patients 
(7.7%; 95% CI: 5.6% - 9.8%). ICAS was symptomatic in 30 patients (4.9%; 95% CI: 
3.2% - 6.7%). Concomitant asymptomatic ICAS was found in 13 of the 30 patients 
with symptomatic ICAS.  
The total number of ICAS lesions was 69, 30 symptomatic and 39 asymptomatic. 
Among the symptomatic lesions, 8 (27%) were <50%, 20 (66%) were 50-69%, and 2 
(7%) were 70%. Among the asymptomatic lesions, 22 (56%) were <50%, 17 (44%) 
were 50-69%, and none was 70%. Moderate-high degree of stenosis (50%) was 
significantly associated with symptomatic ICAS (OR 7.27; 95% CI: 1.63-32.41; 
p<0.01). Diabetes mellitus was the only risk factor significantly associated with 
symptomatic ICAS (OR 2.55; 95% CI: 1.03-6.31, p=0.04). 
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Diagnostic performance of transcranial color-coded 
sonography (Paper II) 
Screening for intracranial stenosis was performed on 278 consecutive patients with 
adequate transtemporal bone window and confirmed ischemic stroke or TIA over a 
10-month study period. At least one M1 or M2-MCA stenosis was diagnosed in 25 
patients (9%) by the continuity equation TCCS method. Four patients were excluded 
because of contraindication to CTA. Twenty-one patients matched the inclusion 
criteria [14 men, 7 women; age (±SD) 74.2 years (12.3)]. All stenosis were confirmed 
by CTA. The 21 patients included into the study presented 40 MCA stenoses, 29 in 
the M1 and 11 in the M2 segments.  
TCCS continuity equation method vs CTA 
The overall correlation coefficient for degree of MCA stenosis between TCCS and 
CTA was 0.85 (p<0.0001), Figure 3.  
&ŝŐƵƌĞϯ͘ŽƌƌĞůĂƚŝŽŶďĞƚǁĞĞŶĚĞŐƌĞĞŽĨƐƚĞŶŽƐŝƐ͗d^ǀƐd  
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The overall correlation coefficient for M1 stenosis was 0.87 (p<0.0001), and for M2 
stenosis 0.71 (p<0.01). Correlation coefficient for MCA stenosis defined with CTA as 
50% was 0.94 (p<0.0001).  
Continuity equation vs cut-off velocity method 
Continuity equation method showed a sensitivity of 78% (14/18) and a specificity of 
86% (19/22) in detection of 50% MCA (M1 and M2) stenosis. Cut-off velocity 
method based on previously published criteria,82 showed a sensitivity of 50% (9/18) 
and a specificity of 91% (20/22) in detection of 50% MCA stenosis, and failed to 
detect 16 stenoses, 4 defined by CTA as 50% and 12 as <50%. The most accurate 
PSVintrastenotic  value for detection 50% MCA stenosis in our patients cohort was 180 
cm/s and provided a sensitivity of 67% (12/18) and a specificity of 86% (19/22). 
When only M1 was considered, continuity equation method showed a sensitivity of 
85% (11/13) and a specificity of 81% (13/16) in detection of 50% M1 stenosis. Cut-
off velocity method based on previously published criteria,82 showed a sensitivity of 
54% (7/13) and a specificity of 94% (15/16) in detection of 50% M1 stenosis, and 
failed to detect 12 stenoses, 2 defined by CTA as 50% and 10 as <50%. The most 
accurate PSVintrastenotic  value for detection of 50% M1 stenosis was 180 cm/s and 
provided a sensitivity of 77% (10/13) and a specificity of 86% (14/16). 
Effect of ultrasound contrast agents on velocity 
measurements (Paper III) 
Ten patients were examined (8 male; median age 56.5 years; age range 35-67 y). 
Blood flow velocity (BFV) measured during UCA infusion with no gain adjustment 
was significantly higher than baseline BFV (PSV: 85.1 ± 19.7 vs. 74.4 ± 19.7 cm/s, 
p<0.0001; MV: 56.5 ± 11.8 vs. 50.2 ± 12.3 cm/s, p<0.0001). The percent increase in 
measured PSV was 16 ± 9% (range 6-33), and the percent increase in measured MV 
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was 14 ± 10% (range 4-33). BFV measured during UCA infusion with gain reduction 
was not significantly higher than baseline BFV (PSV: 74.3 ± 18.9 vs. 74.4 ± 19.4 
cm/s, p=0.8; MV: 49.4 ± 11.0 vs. 50.2 ± 12.3 cm/s, p=0.8). No artefact hindering 
velocity measurement was noted during the recordings.  
In vitro blood flow volume measurements (Paper IV)  
The correlation between the calculated flow index (FI) against the absolute flow was 
strong for each tube size at each hematocrit (Hct) values (r>0.98, p=0.01).  
&ŝŐƵƌĞϰ͘ŽƌƌĞůĂƚŝŽŶďĞƚǁĞĞŶƚŚĞĐĂůĐƵůĂƚĞĚĨůŽǁŝŶĚĞǆĂŶĚƚŚĞĂďƐŽůƵƚĞĨůŽǁ

The correlation between the calculated area index (AI) against the absolute cross-
sectional area (CSA) was strong for each absolute flow volume at each Hct values 
(r>0.99) (Figure 5).  
The effect of varying Hct on flow index is shown in Figure 6. 
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Discussion 
Prevalence of Intracranial Atherosclerosis in ischemic stroke 
and TIA patients  
The focus on intracranial atherosclerosis (ICAS) has dramatically increased over the 
last two decades, and it is now settled that ICAS is one of the leading causes of 
ischemic stroke and TIA worldwide.11 Several studies have shown that the prevalence 
of ICAS is strongly influenced by ethnicity. In Asian ischemic stroke patients, ICAS 
is found in up to half of the cases,11, 106-109 and in African Americans and Hispanics in 
6% and 11% respectively.12 In Caucasians, the prevalence of ICAS varies from 1% in 
White-American12 to 12.4% in Spanish ischemic stroke patients.15 Studies from 
Netherland and Germany reported a prevalence of symptomatic ICAS in ischemic 
stroke patients of 3% and 6.5% respectively.13, 110  
Asians are at the highest risk to develop ICAS, and predisposition toward 
hypoadiponectinemia in this ethnicity may represent a possible explanation.111
Adiponectin is an adipose tissue-specific cytokine found to be reduced in obesity, 
diabetes mellitus type 2, insulin resistance, hyperlipidemia, metabolic syndrome, and 
cardiovascular diseases.112, 113 Adiponectin appears to have a protective role against 
atherosclerosis by inhibiting neointimal formation and suppressing the expression of 
inflammatory cytokines and adhesion molecules.114 Asians appear to have lower 
adiponectin levels than Caucasian subjects of similar age, body mass index and total 
adiposity.111 Low adiponectin levels may therefore play an important pathogenic role 
in development on atherosclerosis, but it is still unclear why low adiponectin levels 
may selectively lead to atherosclerosis in the intracranial vessels.  
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It is also unclear why there is a discrepancy in ICAS prevalence among patients from 
different European countries. The heterogeneity in diagnostic criteria, imaging 
modalities and study populations may be a possible explanation. Diagnostic 
performance in detection of ICAS varies not only between different modalities, but 
also within a specific modality depending on technique, setting and/or diagnostic 
criteria. Diagnostic performance also depends on the investigated vascular territory. 
MRA and ultrasonography both have lower sensitivity in detection of ICAS in the 
posterior circulation, especially in the vertebrobasilar system, compared to the 
anterior circulation,81, 115 and CTA should be considered the posterior circulation gold 
standard in absence of DSA. It may therefore be expected that studies using different 
modalities will report discordant results about the distribution of ICAS lesions in the 
anterior and the posterior circulation. However, there are few and inconclusive data 
answering this hypothesis. One ultrasonographic based study has shown that the 72% 
of symptomatic ICAS lesions were located in the anterior circulation, versus 62% 
reported by one CTA based study.110 This difference was due to the more frequently 
detected ICAS lesion in the posterior cerebral artery by CTA (12.5% vs 4.7%), 
whereas the percent of vertebrobasilar stenosis was similar between the studies (CTA 
25%; TCD 23%).  
In our cohort of patients, ~8% presented at least one ICAS and ~5% had symptomatic 
ICAS. Our results are not directly comparable with other studies since the 
vertebrobasilar system was not investigated. However, assuming a 25% rate of 
symptomatic ICAS in the vertebrobasilar system, as suggested by earlier studies,32, 110
a prevalence of symptomatic ICAS of 6.4% could be expected in our population, 
which is in line with a study from Germany (6.5%)34 (Table 3). In our study, the 
diagnosis of ICAS did not require confirmation by a reference method if one of the 
three modalities detected ICAS, and low-grade symptomatic stenoses (<50%) were 
also included. This approach may theoretically overestimate the prevalence of 
symptomatic ICAS. However, our results are lower than results from studies in 
Southern Europe (9.2 and 12.4%).15, 32 These studies may have underestimated the 
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prevalence of ICAS because of methodological design (e.g. TCD based studies 
excluding patients with poor transtemporal bone window, and requiring confirmation 
of 50% stenosis with MRA/CTA). Methodological variability among European 
studies may therefore not fully explain the regional differences in prevalence of 
symptomatic ICAS. 
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Community-based or hospital-based studies performed in the western part of the 
world have not distinguished between ischemic stroke and TIA patients when 
calculating the prevalence of ICAS. One study from China9 has detected ICAS in 
~50% of TIA patients, thus suggesting that the prevalence of ICAS may not differ 
between TIA and ischemic stroke patients. In our cohort of patients with acute 
cerebral ischemia screened for ICAS, 45 had TIA, of which 5 (11%) presented ICAS 
and 2 (4.5%) symptomatic ICAS. Although the limited sample size does not allow to 
draw definite conclusion, ICAS may occur equally in both ischemic stroke and TIA 
patients also in a Caucasian population.  
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Diagnosis of Intracranial Atherosclerosis 
The Consensus Conference on Intracranial Atherosclerotic Disease held in 2009116
suggested to use the term “intracranial atherosclerosis” for lesions defined by autopsy 
studies, and “intracranial stenosis” for lesions defined by other methods.117 Even 
though both clinical and autopsy studies have the same object of investigation, i.e. the 
intracranial plaque, intracranial atherosclerosis is still an exclusion diagnosis when 
based on vascular imaging. Routine diagnostic methods, i.e. digital subtraction 
angiography, CTA, MRA and ultrasound are accurate in defining intracranial stenosis 
but are not able to visualize the intracranial atherosclerotic plaque. Emerging methods 
for non-invasive visualization of the intracranial atherosclerotic plaque, such as high-
resolution MRI (HR MRI)118 and intravascular ultrasound,119 are promising but 
seldom available.  
There is no consensus on the criteria which intracranial stenosis must fulfill to be 
defined as atherosclerotic, nor any studies comparing the accuracy of the imaging 
diagnosis of intracranial atherosclerosis with the “real” gold standard, i.e. autopsy. 
Inspired by the TOAST classification,120 most studies have defined as atherosclerotic 
those intracranial stenoses which were 50%, with negative work-up for cardiac 
embolism, no severe extracranial stenosis, and no other possible etiology for the 
stenosis, e.g. MoyaMoya disease, vasculitis, or dissection.13, 14, 121-124 This approach 
has some limitations. Intracranial stenoses <50% are excluded because considered as 
“non-significant”.120 However, evidences from both cardiac and carotid 
atherosclerosis have shown that several histological and morphological characteristics 
of the plaque, such as large lipid core, thin fibrous cap, and plaque vascularization, 
may predict plaque rupture independently from the degree of stenosis.89, 125, 126 Even 
though an accurate grading of the intracranial stenosis is important in risk 
stratification of patients,127 it is incorrect to consider a low-grade stenosis as a non-
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threatening lesion. In our study, ~30% of patients with symptomatic intracranial 
atherosclerosis presented lesions which were <50%. 
Detection of low-grade stenosis is not free of pitfalls and challenges. Intracranial 
vessels have smaller diameter and are less accessible than extracranial arteries, and 
the resolution of non-invasive method may not be high enough to detect minor 
irregularities of the vessel wall.128 However, applying continuity equation to 
transcranial ultrasonography may ensure detection of low-grade stenosis. The 
continuity equation states that each reduction in the area of the vessel corresponds to a 
change in blood flow velocity. In theory, even the smallest stenoses should be 
detectable by ultrasound. In practice however, it is not possible to differentiate 
between physiological and pathologically velocity changes if the changes are small, 
since tortuosity, bifurcation, and perforating arteries may lead to physiological 
increase in velocity. We therefore set the minimal detectable area reduction at 26%, 
which corresponds to ~35% focal increase in velocity. All low-grade stenoses 
detected by TCCS applying the continuity equation were confirmed by CTA, 
suggesting that this method is highly accurate. However, remodeling of arteries may 
limit the accuracy of this method.129 This phenomenon, described originally in 
coronary arteries, consists of a compensatory enlargement of the vessel wall which 
allows the plaque to grow outward without compromising neither vessel lumen nor 
blood flow velocity.  
In our patients cohort, 14 out of 114 (12.3%) patients with atrial fibrillation (AF) 
presented >50% extracranial stenosis (ES). Atherosclerosis is therefore not 
uncommon in patients with AF. In case of AF and ES, atherosclerosis is easily 
recognizable with ultrasound, and diffusion-weighted MRI may often help to define 
which of the two is the probable underlying cause of ischemic stroke. An intracranial 
stenosis in patients with AF may represent either a recanalizing cardiac thrombus or 
an intracranial plaque. Excluding a priori patients with AF may therefore 
underestimate the number of ICAS lesions. However, it is difficult to differentiate 
47
between these two conditions with the currently available routine modalities. The 
detection of rapidly improving stenosis at daily ultrasonographic follow-up may 
suggest the presence of a recanalizing thrombus, whereas a more “stable” lesion may 
indicate the presence of ICAS.  
It is also challenging to define whether ICAS lesions are symptomatic or not. Our 
current understanding of the intracranial plaque is limited by the absence of 
standardized methods to detect plaque instability, and is still based on indirect clues, 
such as the location of intracranial stenosis and infarct, and the exclusion of other 
plausible causes. One case-report has shown that HR MRI may visualize intraplaque 
hemorrhage in an intracranial plaque.130 Another study investigating a possible role of 
gadolinium plaque enhancement in patients with severe MCA stenosis, failed to show 
that plaque enhancement is a marker of symptomatic or unstable plaque.131 However, 
the small sample of the study (n=6) does not permit definite conclusions.  
A hopefully higher availability of HR MRI in the future will 1) increase the sensibility 
of non-invasive method in detecting intracranial plaque, especially in an early 
stadium, 2) detect non-stenosing plaque, i.e. plaque undergoing remodeling, 3) ensure 
a better understanding of plaque stability, and 4) help to differentiate a recanalizing 
cardiac embolus from an in situ atherosclerotic plaque. 
Role of ultrasound in the diagnosis of intracranial stenosis 
Transcranial ultrasonography is a non-invasive, bed-side, convenient, and inexpensive 
modality for the evaluation of the intracranial arteries.132 Diagnostic criteria for 
intracranial stenosis are based on the detection of blood flow velocity (BFV) 
exceeding predefined “normal” velocity values. As shown in Tables 1 and 2, 
threshold values appear to provide high diagnostic performance. However, these 
results may not reflect the actual diagnostic performance of TCD and TCCS in an 
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unselected ischemic stroke population. Most studies are affected by selection and 
verification bias, as well as publication bias in favor of the best results. The most 
common verification bias is represented by the availability of the reference method 
only in patients were TCD or TCCS suspected pathology. There is also a considerable 
difference between studies performed in the early 1990s,80 reporting high diagnostic 
performance values, and more recent studies,24, 81 showing lower values, and in 
particularly very low positive predictive values (PPV) (36%).24 There are very few 
studies which have tested TCCS against DSA and current TCCS diagnostic criteria 
for intracranial stenosis are mainly based on one study performed in the late 1990s82
reporting 100% sensitivity, specificity, PPV and negative predictive values of 
threshold velocity 220 cm/s (PSV) for detection of 50% MCA stenosis. Both 
selection and verification bias may have led to such extremely good results. Patients 
included in that study had symptomatic ICAS detected at TCCS (degree 50% may be 
assumed) and/or 70% extracranial stenosis (ES). Patients with ICAS were therefore 
already selected by TCCS, whereas those patients with no ICAS had 70% ES, and 
thus low velocity in the MCA. The difference in velocity between stenotic and normal 
MCA may have been increased by these selection criteria.  
Intracranial velocities vary among subjects depending on age, state of the extracranial 
arteries, hematologic and endocrine disorders. The threshold method may therefore 
either overlook stenosis in subjects with low intracranial velocity or provide false 
positive results in subjects presenting high intracranial velocities. Low intracranial 
velocities are often found in older patients and/or in presence of extracranial high-
grade stenosis. False positive results may be found in patients with disturbed 
autoregulation, in conditions with general increase in blood flow volume and velocity 
such as arteriovenous malformations, anemia or hyperthyreosis, and in case of 
improper angle correction or use of ultrasound contrast agents. The use of absolute 
threshold values may therefore be misleading because it does not take into account 
cerebral hemodynamics as a whole. Other hemodynamic aspects, such as flow 
direction, pre- intra- and poststenotic velocity, comparison of velocity with the 
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contralateral artery and the other ipsilateral arteries, musical murmurs, bruits and 
pulsatility index may help in detection and characterization of the stenosis, and 
possibly provide better diagnostic results. An illustration of how blood flow velocity 
and blood flow volume are influenced by different degree of stenosis is shown in 
Figure 7.  
&ŝŐƵƌĞϳ͘ŽƌƌĞůĂƚŝŽŶƐďĞƚǁĞĞŶďůŽŽĚǀĞůŽĐŝƚǇ͕ďůŽŽĚĨůŽǁĂŶĚƐƚĞŶŽƐŝƐŐƌĂĚŝŶŐ
ĚĂƉƚĞĚĨƌŽŵ^ƉĞŶĐĞƌDW͘^ƚƌŽŬĞϭϵϳϵ͕ϭϬ;ϯͿ͗ϯϮϲͲϯϯϬ
This hypothetical flow model, also known as the Spencer curve,69 is based on the 
Hagen-Poiseuille law and the continuity equation, and applies to an axis-symmetric 
and smooth-surface arterial stenosis in a straight vessel with no bifurcations. 
Although in a clinical setting most stenoses are axis-asymmetric, have irregular 
surface, variable length and compliance, this model represents a “milestone in 
understanding cerebral hemodynamics with long-lasting practical and research 
implications”.133 The curve shows that blood flow velocity increases exponentially 
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and reaches a top which corresponds to ~80% diameter stenosis. As long as the 
increase in velocity is able to keep flow volume constant, it is correct to assume that 
the product of the cross-sectional areas () time the blood velocity (s) is constant 
throughout the vessel, as stated by the continuity equation: ϭΎsϭсϮΎsϮ (Figure 8).  
&ŝŐƵƌĞϴ͘dŚĞĐŽŶƚŝŶƵŝƚǇƉƌŝŶĐŝƉůĞ
сĐƌŽƐƐͲƐĞĐƚŝŽŶĂůĂƌĞĂ
W^sсƉĞĂŬƐǇƐƚŽůŝĐǀĞůŽĐŝƚǇ
The degree of stenosis may be calculated as ΀ϭʹ;W^sƉƌĞƐƚĞŶŽƚŝĐͬW^sŝŶƚƌĂƐƚĞŶŽƚŝĐͿǆϭϬϬ΁й. 
This formula ensures an exact calculation of degree of stenosis, and our study (Paper 
II) has shown that this method is accurate when compared to CTA. Since the risk of 
stroke in the territory of an intracranial stenotic artery appears to be directly 
proportional to the severity of the stenosis,127 accurate calculation of the degree of 
stenosis may have clinical implications. According to the continuity equation, a 
doubling of velocity, which may also be expressed as a ratio between intrastenotic and 
prestenotic velocities of 2, corresponds to 50% stenosis. A ratio 2 between 
intrastenotic and prestenotic velocity may therefore be more accurate than threshold 
values in detection of 50% stenosis. However, a recent TCD study81 has failed to 
show that the use velocity ratio, or the use of either ratio or threshold values, are 
better than threshold values alone in detection of 50% MCA stenosis. This is in 
contrast with our study showing that the use of continuity equation has higher 
accuracy than threshold values in detection 50% MCA stenosis. Although both 
studies are based on continuity equation, the use of two different ultrasound 
technologies, i.e. TCD vs. TCCS, may have led to discordant results. TCD based 
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studies mostly use mean velocities (MV), whereas TCCS based studies commonly use 
peak systolic velocities (PSV). In vitro experiments have shown that calculating the 
degree of stenosis with continuity equation provides the most exact results when PSV 
rather than MV are used.134 TCCS may also provide the most accurate velocity 
measurements because color-coding warrants both optimal placement of small sample 
volume and angle correction all through the artery. Continuity equation may therefore 
be an excellent tool for evaluation of intracranial stenosis, but it cannot be applied to 
the whole spectrum of stenosis. Near occlusive stenoses are characterized by 
abnormal low velocity and blunted Doppler waveforms. “Low velocity findings”, 
defined as reduction 30% in MV compared to the non-stenotic side, plus the 
presence of blunted Doppler waveform, have been proposed as specific diagnostic 
criteria for these stenosis and appear to have high sensitivity.81    
The continuity equation method may theoretically be applied also to other segments of 
the Circle of Willis. The M1 segment is often straight and almost parallel to the 
ultrasound beam, so that small degree of angle correction is required. However, the 
anatomy of the other segments creates challenges. The carotid siphon is extremely 
tortuous and, besides the proximal C5 segment (pars petrosa), is perpendicular to the 
ultrasound beam, thus not allowing angle correction (Figure 9). It is therefore not 
possible to achieve reliable velocity measurements throughout the length of this 
artery. It may be hypothesized that using velocity measurements from the 
corresponding contralateral siphon may be more accurate than ipsilateral prestenotic 
velocity measurements.  
The pars precommunicalis (A1) of the anterior cerebral artery (ACA) may be difficult 
to visualize in one single axial plane and it may therefore be difficult to define 
whether velocity increase is focal or not. Ultrasound scanning in the coronal plane 
may visualize the siphon and the origin of both A1 and M1 in one plane, and may 
therefore clarify if there is a diffuse velocity increase in these segments. Velocity 
increase in A1 is more often due to other conditions than intracranial stenosis, such as  
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&ŝŐƵƌĞϵ͘ŶĂƚŽŵŝĐĂůƐĞŐŵĞŶƚŽĨƚŚĞŝŶƚƌĂĐƌĂŶŝĂůĐĂƌŽƚŝĚŝŶƚĞƌŶĂůĂƌƚĞƌǇ;ƐŝƉŚŽŶͿ
&ƌŽŵsĂůĚƵĞǌĂ:͘EĞƵƌŽƐŽŶŽůŽŐǇĂŶĚŶĞƵƌŽŝŵĂŐŝŶŐŽĨƐƚƌŽŬĞ͘dŚŝĞŵĞ͖ϮϬϬϴϭϯϱ
contralateral internal carotid artery occlusion, stenosis in the ipsilateral C1/C2 
segments, and/or near-occlusive stenosis in the ipsilateral M1. These conditions 
should therefore be ruled out before considering the presence of A1 stenosis. 
The pars infracallosa (A2) of the ACA is usually straight and perpendicular to the 
ultrasound beam, and measurements in this segment must therefore be performed 
without angle correction. However, the low resolution of the color-mode in most of 
the cases does not permit to differentiate between the right and the left segments since 
both segments are visualize as one single segment.    
Continuity equation may theoretically be applied to the P1 segment and the proximal 
part of P2 since they are parallel to the ultrasound beam and optimal angle correction 
is possible. The distal P2 segment is tortuous and does not allow angle correction. As 
for the siphon, using “normal” contralateral velocity may be more accurate than 
ipsilateral prestenotic velocity measurements. 
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Ultrasound contrast agents 
Transcranial ultrasonography is hindered by hyperostosis of the skull, a condition 
which most frequently occurs in elderly subjects, especially females. Due to the 
predominance of elderly among ischemic stroke patients, the lack of transtemporal 
bone window is a problem for neurosonographers working in stroke units. The rate of 
poor transtemporal bone window in our study population (~20%) was in line with 
data reported in earlier studies.93, 94  
The use of modern ultrasound contrast agents (UCA) in patients with poor 
transtemporal bone window ensures adequate ultrasonographic examination in 
virtually all cases.96 However, UCA bolus injection can cause a 20–24 % increase in 
measured peak systolic velocity (PSV),98, 99 and may thereby lead to false-positive 
detection of intracranial stenosis (page 48).   
UCA is usually administered as bolus injection. This way of administration allows 
short and varying contrast enhancement which often leads to artifacts, such as 
blooming, hindering blood flow velocity (BFV) measurements (page 26). The use of 
an infusion pump ensures stable and artifact-free contrast-enhancement not interfering 
with velocity measurements (see Paper III).  
Our study has shown that UCA continuous infusion also leads to an increase (16%) in 
measured BFV. This increase appears to be lower than the one reported for UCA 
bolus injection (20–24%). However, it is not possible to compare these results 
because different ultrasound technologies and UCA were used. 
It is strongly debated why UCA lead to an increase in measured BFV.136, 137 UCA 
have no effects on heart rate or blood pressure,138 and the increase in measured BFV 
is therefore not due to an increase in cardiac output induced by UCA. Microbubbles 
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have intrinsic properties which may influence the back scattered Doppler shift. In 
vitro studies139, 140 have shown that acoustic radiation force may displace 
microbubbles in the ultrasound wave propagation direction and that this can produce 
spectral broadening.140 Spectral broadening has also been observed in vitro when 
microbubbles are ruptured.141 Although these phenomena in vivo may not be as 
evident as in vitro,141, 142 spectral broadening may represent a mechanism behind the 
UCA-related increase in measured BVF.143 Another possible explanation is that UCA 
disclose areas of the blood flow spectrum previously hidden by background noise. 
The laminar blood flow has a parabolic shape with few red blood cells (RBC) moving 
at the highest velocity. The back scattered signal from the fastest RBC may therefore 
be weak and not distinguishable by the background noise. By adding scatterers to the 
blood flow, UCA may disclose areas of the blood flow spectrum previously not 
measurable, such as the fastest flow lamina, but also the slowest flow lamina, and 
hence lead to broadening of the Doppler spectrum. This hypothesis is supported by in 
vivo studies showing that UCA lead to increase in measured BFV only in deeply 
located vessels,144 but not in superficial vessels,145 suggesting that if optimal Doppler 
signal intensity (DSI) is obtained, a further increase in the signal-to-noise ratio does 
not modify BFV, since the highest velocity lamina is already disclosed. 
None of the earlier clinical studies have been able to overcome the UCA-related 
increase in measured BFV. In our study, gain reduction performed during stable 
contrast-enhancement restored the BFV measured at baseline (Figure 10). Gain was 
reduced so that the DSI matched the intensity of the Doppler signal recorded at 
baseline. This was qualitatively performed by looking at one picture of the Doppler 
signal saved at baseline.  
It remains to demonstrate if gain reduction may restore baseline BFV also in patients 
with poor transtemporal window, since no information about the baseline BFV and 
the baseline DSI are available. Our experience with administration of UCA in patients 
with poor temporal bone window suggests that infusion rate of 0.4 – 0.5 ml/min 
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allows artifact-free visualization of the circle of Willis. The Doppler spectrum 
detected in such conditions has higher intensity compared to subjects with optimal 
transtemporal bone window and no UCA infusion. It may be hypothesized that gain 
reduction restoring the Doppler signal to low intensity may neutralize the effect of 
UCA on measured BFV also in patients with poor temporal bone during stable 
contrast-enhancement. This hypothesis might be tested by simulating the presence of 
skull hyperostosis with aluminium foil in patients with optimal transtemporal bone 
window.   
&ŝŐƵƌĞϭϬ͘ŽƉƉůĞƌƐŝŐŶĂůĂƚĚŝĨĨĞƌĞŶƚƌĞĐŽƌĚŝŶŐƉŚĂƐĞƐ


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ďͿŽƉƉůĞƌƐŝŐŶĂůĚƵƌŝŶŐhŝŶĨƵƐŝŽŶǁŝƚŚŶŽŐĂŝŶƌĞĚƵĐƚŝŽŶ͘W^sсϲϵĐŵͬƐ
ĐͿŽƉƉůĞƌƐŝŐŶĂůĚƵƌŝŶŐhŝŶĨƵƐŝŽŶĂĨƚĞƌŐĂŝŶƌĞĚƵĐƚŝŽŶ͘W^sсϱϰĐŵͬƐ
Blood flow volume measurements 
Transcranial ultrasonography infers cerebral hemodynamics from blood flow velocity 
measurements. However, the relationship between blood velocities and blood volume 
is complex, and velocities alone may in some cases incorrectly evaluate the 
intracranial vessels and the cerebral blood flow volume. Flow impairment is detected 
by velocity only in cases of near-occlusive stenosis (Figure 7, page 49; “low findings 
criteria”, page 51). In case of less severe stenosis (approximately >60%) velocity 
Ă ď Đ
56
alone may lead to ambiguous results for both flow volume and degree of stenosis 
(Figure 7). Besides the degree of intracranial stenosis, flow volume is influenced by 
several other factors, such as the coexistence of extracranial stenosis and the collateral 
status. Neither degree of stenosis nor velocities are therefore sufficient to define 
which stenosis causes blood flow volume impairment, i.e. “really” is significant. 
Measurements of the cerebral blood flow volume may therefore provide a deeper 
understanding of the cerebral hemodynamics and have diagnostic, therapeutic and 
prognostic implication in acute ischemic stroke patients.   
Our study (Paper 4) has shown that blood flow volume may be accurately estimated 
by analysing the power Doppler and the Doppler shift. This method may detect 
relative changes in flow volume, but does not provide absolute flow values. One 
possible clinical application of this method may be represented by monitoring of the 
flow index before and after manoeuvres or agents inducing changes in the peripheral 
resistances. This may be an accurate and sensitive method to test the cerebrovascular 
reserve capacity (vasoreactivity) in patients with acute ischemic strokes, and also in 
other neurological conditions.   
The feasibility and accuracy of this method depend on the quality of the Doppler 
signal. The advent in the near future of probes continuously and automatically 
searching for the optimal Doppler signal may further improve our ability to measure 
relative changes in blood flow volume.  
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Conclusions  
The epidemiological data on ICAS provided by our study add information about the 
prevalence and distribution of this disease in Europe. Although the prevalence of 
ICAS appears to be relative low, an in depth etiological and pathophysiological 
understanding of ischemic stroke and TIA has important clinical and prognostic 
consequences. Patients with ICAS have high recurrence risk (up to ~40% of the 
patients within a 2-year period)146 and therefore need aggressive secondary medical 
prevention. Screening for ICAS should therefore be part of the routine work-up in all 
ischemic stroke and TIA patients. Transcranial color-coded sonography (TCCS) is the 
perfect tool to perform ICAS screening in stroke units. TCCS is inexpensive, non-
invasive, and gives accurate information on the intracranial vessels. Knowledge of 
basic hemodynamic and physical principles is necessary to fully exploit the potential 
of TCCS. This work has shown that the application of continuity equation may 
increase the accuracy of TCCS in both detection and grading of ICAS compared to 
conventional diagnostic criteria. Degree of stenosis is the most important prognostic 
factor in ICAS patients,127 and accurate grading of ICAS is therefore essential in the 
evaluation of these patients.  
This work has also focused on patients in which optimal TCCS examination is 
hindered by hyperostosis of the skull. This problem occurs in 20% of ischemic stroke 
patients, but may be overcome in virtually all patients by ultrasound contrast agents 
(UCA). However, UCA cause an unexplained increase in blood flow velocity which 
may bias diagnostic results. This work has shown that the use of infusion pump and 
optimal gain reduction may overcome the undesired increase in blood flow velocity 
related to UCA administration. 
Finally, advanced analysis of the Doppler spectrum has been investigated aiming to 
provide information of the cerebral hemodynamics beyond mere velocities. Our in 
58
vitro experiments have shown that analysis of the Doppler signal power provides 
reliable measurements of relative changes in blood flow volume. This may represent a 
first step towards a more accurate evaluation of the cerebral autoregulation, possibly 
providing a deeper hemodynamic understanding of the intracranial atherosclerotic 
plaque.  
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